Schrödinger to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence

Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) announced CEO Ramy Farid, Ph.D., will participate in a virtual panel during the Credit Suisse 2021 Healthcare Innovators Series on March 23 at 2:00 p.m. ET. The event focuses on the intersection of drug discovery, drug development, and artificial intelligence. An on-demand webcast will be available on Schrödinger's website and archived for about 7 days. Schrödinger aims to transform therapeutic and material discovery through its physics-based software platform, enhancing efficiency and reducing costs for global organizations.

Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that Ramy Farid, Ph.D., chief executive officer at Schrödinger, will participate in a panel during the Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence. The panel will take place virtually on Tuesday, March 23, at 2:00 p.m. ET.

The “on demand” webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar and will be archived for approximately 7 days.

About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrödinger has over 450 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com and follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210317005039/en/

FAQ

What event will Ramy Farid of SDGR participate in?

Ramy Farid will participate in the Credit Suisse 2021 Healthcare Innovators Series panel on March 23, 2021.

When is the Schrödinger panel discussion scheduled?

The panel discussion is scheduled for March 23, 2021, at 2:00 p.m. ET.

Where can I access the webcast for the SDGR panel?

The on-demand webcast can be accessed on Schrödinger's website under 'News & Events'.

How long will the Schrödinger panel discussion be available for viewing?

The webcast will be archived for approximately 7 days after the event.

What is the focus of the Credit Suisse Healthcare Innovators Series panel?

The panel focuses on the intersection of drug discovery, drug development, and artificial intelligence.